In an amicus brief filed with the United States Court of Appeals for the Federal Circuit regarding the ACLU-Myriad gene patenting case, James Watson argues that genes should not be patented. (Duke University's Center for Public Genomics has posted the brief here.) Watson writes that genes are a product of nature and encode "vital information" that directs whether a person is male or female, or blonde or brunette.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.